Clinical Trial Update: Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral MOA-728 for opioid-induced bowel dysfunction in chronic non-malignant pain was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Opioid-induced Constipation

Drugs mentioned

• MOA-728

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Constipation | Phase 2 | Status: COMPLETED